百家乐怎么玩-澳门百家乐官网娱乐城网址_网上百家乐是不是真的_全讯网888 (中国)·官方网站

Mapping a biotech future in Hong Kong

Regina Lau

 

Recent biotech achievements in China offer immense opportunities for Hong Kong to enhance her position in biotechnology, one of the most promising industries for coming decades, said Professor Y L Lo, Founding Chairman of the Hong Kong Biotechnology Association, at CityU on 20 January. Professor Lo's lecture, "Biotechnology-the Catalyst of Hong Kong's Future Economic Development?" was the latest in the Distinguished Industrialist Lecture Series, organized by CityU's Faculty of Science and Engineering to foster closer links between the University community and the business sector. "Collaborating with China and participation in i

nternational biotech projects are crucial steps for Hong Kong to establish itself in this mega trend for the 21st century," he told the audience.

Professor Lo, who is also the President (Asia Pacific) of PerkinElmer Life and Sciences (Hong Kong) Limited, a US based biotech company, gave a comprehensive picture of biotech development in the Asia Pacific region, which is set to become the engine for global economic growth. Governments in Taiwan, Korea, Singapore and Japan have shown a clear commitment to expanding the biotech industry, which has also experienced booming investment from the private sector. With her growing contributions to the Human Genome Project, breakthroughs in decoding the hybrid rice genome, and production of recombinant drugs and vaccines, China is capable of becoming a future leader in the Asia biotech industry, he said.

"In Hong Kong, the biotech industry is currently very much trade-based. We are lagging behind our neighbors in terms of technological innovation and R&D investment," said Professor Lo. "But with a strong service base, heightened awareness among our entrepreneurs of the huge potential of the life science industry, and our position as China's bridge to the world, Hong Kong is well situated to find a niche in the booming biotech field."

The process of commercialization and technology transfer in biotechnology creates huge opportunities for various sectors, including the legal and fina

nce sectors. Instead of starting from scratch, Hong Kong should focus on the advanced stages of the process, Professor Lo said. "Immense opportunities in servicing and intellectual property protection at the advanced stage of the process are waiting to be explored." 

 

YOU MAY BE INTERESTED

Contact Information

Communications and Institutional Research Office

Back to top
真人百家乐官网代理合作| 澳门顶级赌场手机版| 海立方百家乐官网的玩法技巧和规则| 马牌百家乐官网的玩法技巧和规则| 百家乐开户最快的平台是哪家| 威尼斯人娱乐场骗人| 湘乡市| 百家乐单跳双跳| 亚洲博彩网| 百家乐官网免费试玩游戏| 百家乐论坛在线提供| 江西省| 大玩家百家乐的玩法技巧和规则 | 澳门百家乐官网技巧经| 福布斯百家乐官网的玩法技巧和规则| 将军百家乐的玩法技巧和规则 | 威尼斯人娱乐城存款多少起存| 百家乐官网网络投注| 百家乐de概率| 阜城县| 百家乐讯特| 百家乐官网真人娱乐场开户注册 | 金海岸百家乐官网娱乐城| 金赞百家乐的玩法技巧和规则 | 澳门百家乐游戏官网| 最好的百家乐官网好评平台都有哪些 | 巨野县| 百家乐代理条件| 巴宝莉百家乐官网的玩法技巧和规则 | 大发888 备用6222.co| 博彩网百家乐中和局| 百家乐官网里什么叫洗码| 大发888赌场的微博| 乐天堂百家乐娱乐城| 百家乐补牌规律| 澳门百家乐官网规律星期娱乐城博彩 | 全讯网bbin888.com| 百家乐投注法| 实战百家乐官网十大取胜原因百分百战胜百家乐官网不买币不吹牛只你能做到按我说的.百家乐官网基本规则 | 百家乐游戏机在哪有| 明溪百家乐官网的玩法技巧和规则|